200 related articles for article (PubMed ID: 8513333)
1. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome.
Ohlsson R; Nyström A; Pfeifer-Ohlsson S; Töhönen V; Hedborg F; Schofield P; Flam F; Ekström TJ
Nat Genet; 1993 May; 4(1):94-7. PubMed ID: 8513333
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome.
Sun FL; Dean WL; Kelsey G; Allen ND; Reik W
Nature; 1997 Oct; 389(6653):809-15. PubMed ID: 9349812
[TBL] [Abstract][Full Text] [Related]
3. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
Weksberg R; Shen DR; Fei YL; Song QL; Squire J
Nat Genet; 1993 Oct; 5(2):143-50. PubMed ID: 8252039
[TBL] [Abstract][Full Text] [Related]
4. Parental genomic imprinting of the human IGF2 gene.
Giannoukakis N; Deal C; Paquette J; Goodyer CG; Polychronakos C
Nat Genet; 1993 May; 4(1):98-101. PubMed ID: 8099843
[TBL] [Abstract][Full Text] [Related]
5. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome.
Hedborg F; Holmgren L; Sandstedt B; Ohlsson R
Am J Pathol; 1994 Oct; 145(4):802-17. PubMed ID: 7943172
[TBL] [Abstract][Full Text] [Related]
6. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype.
Murrell A; Heeson S; Cooper WN; Douglas E; Apostolidou S; Moore GE; Maher ER; Reik W
Hum Mol Genet; 2004 Jan; 13(2):247-55. PubMed ID: 14645199
[TBL] [Abstract][Full Text] [Related]
7. Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.
Suzuki S; Renfree MB; Pask AJ; Shaw G; Kobayashi S; Kohda T; Kaneko-Ishino T; Ishino F
Mech Dev; 2005 Feb; 122(2):213-22. PubMed ID: 15652708
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of Beckwith-Wiedemann syndrome.
Weksberg R; Squire JA
Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CDKN1C in Beckwith Wiedemann syndrome.
Algar E; Brickell S; Deeble G; Amor D; Smith P
Hum Mutat; 2000; 15(6):497-508. PubMed ID: 10862080
[TBL] [Abstract][Full Text] [Related]
10. Developmental regulation of genomic imprinting of the IGF2 gene in human liver.
Davies SM
Cancer Res; 1994 May; 54(10):2560-2. PubMed ID: 8168079
[TBL] [Abstract][Full Text] [Related]
11. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
12. Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: implications for hemihyperplasia, associated neoplasms, and overgrowth.
Cohen MM
Am J Med Genet; 1994 Aug; 52(2):233-4. PubMed ID: 7802016
[No Abstract] [Full Text] [Related]
13. Beckwith-Wiedemann syndrome and the insulin-like growth factor-II gene. Does the genotype explain the phenotype?
Witte DP; Bove KE
Am J Pathol; 1994 Oct; 145(4):762-5. PubMed ID: 7943167
[No Abstract] [Full Text] [Related]
14. Promoter-dependent tissue-specific expressive nature of imprinting gene, insulin-like growth factor II, in human tissues.
Wu HK; Squire JA; Song Q; Weksberg R
Biochem Biophys Res Commun; 1997 Apr; 233(1):221-6. PubMed ID: 9144427
[TBL] [Abstract][Full Text] [Related]
15. Inherited and Sporadic Epimutations at the IGF2-H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumor.
Riccio A; Sparago A; Verde G; De Crescenzo A; Citro V; Cubellis MV; Ferrero GB; Silengo MC; Russo S; Larizza L; Cerrato F
Endocr Dev; 2009; 14():1-9. PubMed ID: 19293570
[TBL] [Abstract][Full Text] [Related]
16. [Epigenetic modification of the genetic material. Genomic imprinting and its significance for disease in human beings].
Brøndum-Nielsen K; Pedersen ML
Ugeskr Laeger; 2001 Jun; 163(23):3218-22. PubMed ID: 11421188
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor 2 cannot be linked to a familial form of Beckwith-Wiedemann syndrome.
Nyström A; Hedborg F; Ohlsson R
Eur J Pediatr; 1994 Aug; 153(8):574-80. PubMed ID: 7957404
[TBL] [Abstract][Full Text] [Related]
18. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor.
Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Lausch E; Reutzel D; Fees S; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
Nat Genet; 2005 Aug; 37(8):785-6; author reply 786-7. PubMed ID: 16049499
[No Abstract] [Full Text] [Related]
19. Molecular analysis of a patient with Beckwith-Wiedemann syndrome, rhabdomyosarcoma and renal cell carcinoma.
Matsumoto T; Kinoshita E; Maeda H; Niikawa N; Kurosaki N; Harada N; Yun K; Sawai T; Aoki S; Kondoh T
Jpn J Hum Genet; 1994 Jun; 39(2):225-34. PubMed ID: 8086640
[TBL] [Abstract][Full Text] [Related]
20. CDKN1C expression in Beckwith-Wiedemann syndrome patients with allele imbalance.
Algar EM; Deeble GJ; Smith PJ
J Med Genet; 1999 Jul; 36(7):524-31. PubMed ID: 10424812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
